Physician profile
Patrick K Jones
NPI 1306370051
$637.73
in general payments reported to CMS, 2019-2025
13 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $75.26 · 2021: $195 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $106.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $142.89 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $90.19 | 2021 | |
| Intuitive Surgical, INC. | $82.46 | 2025 | |
| Abiomed | $59.84 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.16 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $54.45 | 2019 | |
| Abbvie INC. | $33.31 | 2021 | |
| Mylan Specialty L.P. | $31.22 | 2020-2021 | |
| Johnson & Johnson Vision Care, INC. | $24.15 | 2025 | |
| Pfizer INC. | $21.90 | 2021 | |
| Amarin Pharma, INC. | $15.57 | 2020 | |
| Merck Sharp & Dohme LLC | $14.23 | 2021 | |
| Medtronic Vascular, INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.